May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ...
ESC
This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.
June 5, 2024 — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data ...
May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...
May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...
May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms ...
May 13, 2024 — Even though mortality and hospitalization rates have improved, the quality of life for those living with ...
May 1, 2024 — A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is ...
May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...
April 29, 2024 — Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to ...
April 10, 2024 — A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular ...
April 10, 2024 — An international consensus statement on how to treat atrial fibrillation with catheter or surgical ...
February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...
November 22, 2023 — The first clinical trial to challenge the routine implantation of a defibrillator in myocardial ...
September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...
September 5, 2023 — New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-in ...
September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...